TELFORD, Pa.--(BUSINESS WIRE)--Draeger Medical, Inc. today announced FDA 510k clearance for its new Infinity® TeleSmart system featuring a compact device capable of monitoring ECG and SpO2. Infinity TeleSmart provides the performance of a full-size patient monitor, packaged in a compact patient-worn telemetry device for adult and pediatric patients. Built-in ACE® (Arrhythmia Classification Expert) and pacer detection algorithms enhance ECG processing and reduce false alarms.